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The long-term health outcome of prenatal exposure to arsenic has been associated with increased mortality in human
populations. In this study, the extent to which maternal arsenic exposure impacts gene expression in the newborn was
addressed. We monitored gene expression profiles in a population of newborns whose mothers experienced varying
levels of arsenic exposure during pregnancy. Through the application of machine learning–based two-class prediction
algorithms, we identified expression signatures from babies born to arsenic-unexposed and -exposed mothers that
were highly predictive of prenatal arsenic exposure in a subsequent test population. Furthermore, 11 transcripts were
identified that captured the maximal predictive capacity to classify prenatal arsenic exposure. Network analysis of the
arsenic-modulated transcripts identified the activation of extensive molecular networks that are indicative of stress,
inflammation, metal exposure, and apoptosis in the newborn. Exposure to arsenic is an important health hazard both
in the United States and around the world, and is associated with increased risk for several types of cancer and other
chronic diseases. These studies clearly demonstrate the robust impact of a mother’s arsenic consumption on fetal gene
expression as evidenced by transcript levels in newborn cord blood.
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Introduction
Arsenic is a ubiquitous environmental pollutant and a
known human carcinogen [1]. Chronic arsenic exposure is an
important public health hazard around the world, with
millions of people exposed to drinking water with levels far
exceeding the guideline of 10 lg/l established by the WHO.
Exposure to arsenic-contaminated drinking water is alarm-
ingly high in many countries, most notably Bangladesh, where
.25 million people are chronically exposed to extreme
arsenic levels. Arsenic contamination is also a signiﬁcant
health concern in the United States, with numerous public
water supplies measuring above the WHO limit [2].
Epidemiological studies indicate that chronic arsenic
exposure in drinking water is associated with increased risk
of skin, bladder, lung, liver, and kidney cancer [1]; in 1987,
arsenic was classiﬁed as a Group 1 carcinogen by the
International Agency for Research on Cancer. Although the
mechanism of arsenic-induced carcinogenesis is not clearly
established, it has been attributed to genotoxicity associated
with reactive oxygen species [3]. Arsenic is also implicated in
other human diseases such as vascular disorders, peripheral
neuropathy, bronchiecstasis, and diabetes [1].
The long-term health consequences of prenatal arsenic
exposure in human populations are pronounced, with
increased mortality rates caused by prenatal and early
childhood exposures [4]. The detrimental health impact of
prenatal arsenic exposure has also been shown in rodent
models where in utero arsenic exposure resulted in a striking
carcinogenic response (5-fold increase in hepatocellular
carcinomas) among offspring; in utero arsenic exposure also
changed the expression of genes involved in cell prolifer-
ation, stress, and cell–cell communication that are evident
even when the offspring reach adulthood. These results have
profound implications suggesting that in utero arsenic
exposure may result in epigenetic changes that persist
through the life of the organism, ultimately impacting health
status. A landmark study in mouse models shows that, indeed,
in utero exposures via the maternal diet can cause permanent
gene expression changes in the offspring that affect suscept-
ibility to disease in the adult [7].
Given the implications of prenatal exposure on human
health and the known public health hazard of chronic arsenic
exposure, we set out to establish the extent to which maternal
arsenic exposure in a human population impacts newborn
gene expression. Additionally, these studies were aimed at
understanding exactly how arsenic affects biological systems
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therefore potential biomarkers, of prenatal arsenic exposure.
Results
Our study was based in the Ron Pibul and Bangkok districts
of Thailand (Figure S1). The ﬁrst case of arsenicosis (arsenic
poisoning) in Thailand was reported in 1987 from the Ron
Pibul district [8]. Rather than natural leaching of arsenic from
geologic sources, Ron Pibul arsenic contamination is attrib-
uted to tin mining that took place from the 1960s to the
1980s. Arsenic concentrations in groundwater and shallow
wells have been classiﬁed at a mean level of 503.5 lg/l, about
50 times higher than WHO guidelines [9].
Using a population of arsenic-exposed and -unexposed
mothers (as deﬁned by WHO standards of chronic exposure
to ;10 lg/l arsenic), we set out to identify gene expression
changes in the cord blood of newborns signiﬁcantly associ-
ated with the extent of prenatal arsenic exposure. Cord blood
is derived almost exclusively from the fetus; therefore, gene
expression changes assessed in cord blood are representative
of the newborn [10]. For this study, exposure classiﬁcation
was based on arsenic concentration in the mother’s toenails,
as this is representative of long-term arsenic accumulation
[11,12]. Toenail samples were taken from a population of 32
volunteer subjects to quantify arsenic exposure in the
mothers. A level of 0.5 lg/g toenail arsenic corresponds to
chronic consumption of water with ;10 lg/l (see Materials
and Methods), which is the ofﬁcial WHO maximum recom-
mended concentration of arsenic in drinking water [11,12].
For the purposes of this study, women with toenail arsenic
levels of ,0.5 lg/g were considered unexposed, and women
with toenail levels of  0.5 lg/g were considered exposed. The
levels of toenail arsenic across the 32 pregnant women ranged
from 0.1 to 68.63 lg/g (Figure 1A). Given the paucity of
available unexposed newborn cord blood from Ron Pibul, the
experimental design required additional utilization of un-
exposed newborn cord blood samples from Bangkok.
Gene Expression Signatures Highly Predictive of Arsenic
Exposure
We set out to determine whether gene expression changes
in a set of infants born to arsenic-exposed women versus
unexposed women (as judged by WHO guidelines) could be
used to predict arsenic exposure in a test population. For
these analyses, two-class prediction was employed, where a
training population was used to derive gene sets that were
then tested as predictors of exposure in a separate
population. The analyses were carried out in two phases: (i)
where the training population was selected at random and
the analyst ‘‘blinded’’ to arsenic exposure level in the test
population and (ii) where all arsenic exposure levels of the
population were revealed and used to deﬁne new training
populations.
The ﬁrst training population comprised 13 newborn
subjects selected at random from the 32 newborns (Figure
1A). Speciﬁcally, RNA was extracted from cord blood of
newborns 1–13, and hybridized to whole human genome
arrays (Materials and Methods). To identify genes whose
expression was associated with prenatal arsenic exposure, we
used an approach that combined differential expression
testing between the populations, plus a positive or inverse
correlation of expression with increasing arsenic exposure
(Materials and Methods). From the 13 newborn subjects, we
identiﬁed the ﬁrst expression signature (ﬁrst gene set, Figure
1B) composed of 170 genes (Table S1) that differentiated the
unexposed newborns (subjects 1–6) from the arsenic-exposed
newborns (subjects 7–13). This prenatal arsenic exposure
expression signature of 170 genes was then used to predict
prenatal exposure in the remaining population of 19
newborns (subjects 14–32). The percent accuracy of class
prediction was determined post-analysis by revealing the
arsenic exposure of the test population to the analyst.
Expression of these 170 genes accurately predicted prenatal
arsenic exposure in 15 of 19 (79%) of the newborns (Figure
1B).
When the arsenic levels of the entire population were
revealed, it became apparent that the ﬁrst training popula-
tion was composed of newborns with a wide range of
exposure levels distributed over almost the entire range
(Figure 1B). We hypothesized that a training population
based on extreme exposures might yield higher predictive
capacity. To assess this, arsenic-associated genes were
identiﬁed using newborns at the extremes of arsenic
exposure (i.e., the lowest versus the highest exposures) as
the second training population (Figure 1A, second training
population). Six newborns comprised the low-exposure
population (subjects 1, 14, 15, 2, 16, and 3), and six newborns
comprised the high-exposure population (subjects 29, 30, 12,
13, 31, and 32) (Figure 1A). As with the ﬁrst gene set,
differential expression testing and correlation analysis
identiﬁed an expression signature, this time composed of
38 genes (Table S2) that differentiated infants born to
mothers with very low and very high arsenic exposure levels
(Figure 1A). These 38 genes were used to predict arsenic
exposure in the remaining test population of 20 newborns.
Even though the gene set was smaller (38 versus 170),
prediction was just as high as that of the ﬁrst gene set, with
prenatal arsenic exposure accurately predicted in 16 of 20
(80%) of the newborns (Figure 1B, second test population).
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Author Summary
Arsenic is an environmental pollutant and known human carcino-
gen. Chronic exposure to arsenic-contaminated water is an
important public health hazard around the world, including the
United States, with millions exposed to drinking water with levels
that far exceed World Health Organization (WHO) guidelines. Given
the implications of prenatal exposure on human health and the
known public health hazard of chronic arsenic exposure, this study
was aimed at establishing the extent to which maternal arsenic
exposure in a human population affects newborn gene expression.
The authors show that prenatal arsenic exposure in a human
population results in alarming gene expression changes in newborn
babies. The gene expression changes monitored in babies born to
mothers exposed to arsenic during pregnancy are highly predictive
of prenatal arsenic exposure in a subsequent test population. The
study establishes a subset of just 11 transcripts that captured
maximal predictive capability that could prove promising as genetic
biomarkers of prenatal arsenic exposure. Pathway analysis of the
genome-wide response in the babies exposed to arsenic in utero
indicates robust activation of an integrated network of pathways
involving NF-jB, inflammation, cell proliferation, stress, and
apoptosis. This study contributes to our understanding of biological
responses to arsenic exposure.We next determined whether a training population derived
from a combination of all of the training samples used to
generate the ﬁrst and second gene set would yield an
expression signature with higher predictive capacity. This
third training population was composed of nine unexposed
newborns and 11 exposed newborns (Figure 1A). Differential
expression testing and correlation analysis identiﬁed an
expression signature of 11 genes (Figure 1B) that could
predict prenatal arsenic exposure in 10 of 12 (83% accuracy)
of the remaining newborn test population (Figure 1B). It is
noteworthy that with only 11 genes, the power of prediction
is as high as the ﬁrst and second gene sets.
Many of the genes in the third gene set were represented in
the gene sets derived from the ﬁrst and second training
populations. Speciﬁcally, ﬁve of the 11 were identiﬁed in the
ﬁrst gene set and all 11 were present in the second gene set
(Table 1). Given the high predictive capacity of these 11
genes, we hypothesize that these are key genes involved in the
prenatal response of babies to arsenic and represent
potential biomarkers of arsenic exposure. The potential
arsenic biomarker set is composed of transcripts for the
CXL1, DUSP1, EGR-1, IER2, JUNB, MIRN21, OSM, PTGS2,
RNF149, SFRS5, and SOC3 genes (Table 1). The dose response
of expression level of each of the identiﬁed biomarkers is
evident when plotted versus arsenic exposure across the
population (Figure S2). Furthermore, to substantiate the
association of the expression of the biomarkers with arsenic
exposure, a multivariate model was employed (Materials and
Figure 1. Gene Expression Signatures Predict Arsenic Exposure in Test Populations
(A) A population of newborns (subjects 1–32) born to mothers with varying levels of arsenic exposure was used to establish arsenic-associated gene
expression signatures. Arsenic exposure levels were determined by maternal toenail arsenic concentration (lg/g). Babies born to unexposed (yellow) or
arsenic-exposed mothers (green) were classified based on WHO guidelines with the cut point demarcated by the red dotted line. Subjects used in the
populations to establish arsenic-associated gene sets are indicated with a white box. For two-class prediction, those subjects not included in the
training population comprise the test population and are indicated with a black box.
(B) Three arsenic expression signatures (gene sets) were derived from populations spanning the range of arsenic exposure (first gene set), at the
extremes of exposure (second gene set), or a combined population of the previous two (third gene set). To be included in the gene set, the transcript
had to not only be differentially expressed (on average) between the exposed and unexposed groups, but also display a significant trend across
increasing arsenic exposure levels. Expression values are mean centered with high relative expression indicated in red and low relative expression
indicated in blue. The three derived gene sets (170 genes, 38 genes, or 11 genes) were used to predict prenatal arsenic exposure in test populations
where correct classification is indicated by a red number.
doi:10.1371/journal.pgen.0030207.g001
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of association of expression with two factors: (i) arsenic
exposure and (ii) geographic source of samples (Materials and
Methods). Geographic source was determined to be a
nonsigniﬁcant factor for the expression level of the bio-
markers (p ¼ 0.11), whereas arsenic exposure was determined
to be a highly signiﬁcant factor (p¼1.3310
 9). Furthermore,
for the set of biomarkers, the two factors of arsenic exposure
and geographic source were not associated (p ¼ 0.77).
Notably, associated molecular functions for the 11 gene
products include stress response and cell cycle regulation.
The zinc ﬁnger DNA binding transcription factor EGR-1
(early growth response 1) is related to cell proliferation and is
induced by mitogens such as EGF [13]. EGR-1 regulates both
proinﬂammatory cytokine activation and p53 transcription
[14,15]. Not surprisingly, as EGR-1 is known to activate
cytokines, such signaling molecules are present in the arsenic
biomarker gene set; namely, OSM (oncostatin M), a member
of the interleukin-6 (IL-6) family of cytokines known to
control cell cycle progression [16], CXL1 (chemokine ligand
1), and SOC (suppressor of cytokine signaling 3). Additionally,
DUSP1 (dual speciﬁcity phosphatase 1) is involved in cell cycle
regulation and is known to modulate cytokine expression
[17,18]. An inﬂammation-activated acute phase response is
indicated by the presence of the JUNB transcription factor,
and IER2 (immediate early response 2) transcripts in the
biomarker set.
Genome-Wide Changes Associated with Prenatal Arsenic
Exposure Are Robust
For a more global assessment of the impact of prenatal
arsenic exposure on fetal gene expression, all biological
pathways modulated in response to arsenic exposure were
identiﬁed by studying the ontology of all the genes differ-
entially expressed between the exposed and unexposed
newborns across the entire population. For these analyses,
the entire newborn population was used (the fourth
population, Figure 1A) to deﬁne the fourth gene set that
was differentially expressed between the two populations: the
21 newborns whose mothers were exposed to arsenic and the
11 newborns whose mothers were unexposed. It should be
noted that for this analysis of global changes between the
populations, the requirement for correlation with increasing
arsenic exposure was not imposed (Materials and Methods).
This analysis identiﬁed 447 genes differentially expressed
between the two populations of newborns, of which 404
(90%) were upregulated (Figure 2A; Table S3). Gene ontology
enrichment analysis was performed to classify the genes
modulated by prenatal arsenic exposure (Materials and
Methods). This analysis identiﬁed ten gene ontology catego-
ries that were signiﬁcantly enriched in the list of 447 genes
(Table 2). Among the gene ontology categories that are
signiﬁcantly enriched are immune and inﬂammatory re-
sponse (p , 0.001) (Table 2).
As an alternative approach to determine if groups of genes
with common function are differentially expressed between
the two newborn populations (arsenic exposed or unex-
posed), we have employed the knowledge-based Gene Set
Enrichment Analysis (GSEA) (Materials and Methods). GSEA
identiﬁed signiﬁcant enrichment (false discovery rate [FDR]
q-value , 0.01) of ten expression signatures with common
biological function that are differentially expressed between
the unexposed and exposed newborns. The groups of genes
include three that represent stress-response signatures and
three that represent tumor/cancer signatures (Table 3). The
GSEA results also highlight that genes associated with
estrogen receptor signaling are differentially expressed
between the unexposed and exposed newborn populations
(Table 3).
Arsenic-Modulated Networks Represent Numerous
Biological Processes
We next determined whether known molecular interac-
tions exist among the proteins encoded by the arsenic
modulated transcripts. Of the 447 arsenic modulated tran-
scripts, 285 gene products were identiﬁed in the Ingenuity
knowledge base and overlayed with known human molecular
interactions (Materials and Methods). Among these proteins,
we identiﬁed the presence of a large arsenic-modulated
interacting network of proteins (Figure 2B). Speciﬁcally, we
identiﬁed a large interacting network comprised of 105
human proteins encoded by arsenic-modulated transcripts
(indicated as red and green nodes) (Figure 2B; Table S4). The
probability of ﬁnding 105 arsenic-modulated transcripts that
encode for a protein network of this size by chance is p ,
Table 1. Potential Gene Biomarkers of Prenatal Arsenic Exposure—Third Gene Set
Gene Description Representative
Public ID
Affymetrix
Probeset ID
*Present in First
Gene Set
*Present in Second
Gene Set
CXCL1 chemokine (C-X-C motif) ligand 1 NM_001511 204470_at *
DUSP1 dual specificity phosphatase 1 NM_004417 201041_s_at **
EGR1 early growth response 1 NM_001964 201694_s_at **
IER2 immediate early response 2 NM_004907 202081_at **
JUNB jun B proto-oncogene NM_002229 201473_at *
MIRN21 microRNA 21 BF674052 224917_at **
OSM oncostatin M AI079327 230170_at **
PTGS2 prostaglandin-endoperoxide synthase 2 NM_000963 204748_at *
RNF149 ring finger protein 149 AI640483 235536_at *
SFRS5 splicing factor NM_006925 203380_x_at *
SOC3 suppressor of cytokine signaling 3 BG035761 206359_at *
Genes with expression significantly associated with prenatal arsenic exposure in a training population were identified and are highly predictive of arsenic exposure in a test population.
doi:10.1371/journal.pgen.0030207.t001
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 55. Of the 105 proteins, 96 (91%) had transcripts that were
upregulated in response to arsenic exposure.
Further analysis identiﬁed three highly signiﬁcant (p ,
10
 55) sub-networks embedded within the large interacting
network (Figure 3A–3C). The ﬁrst sub-network centers
around the nuclear transcription factor NF-jB and the pro-
inﬂammatory interleukin 1 family member IL1-b (Figure 3A).
This network integrates two members of the potential
biomarkers; namely, SOC3 and CXCL1 (Figure 3A). Note
that transcripts for all proteins directly associated with NF-jB
in this sub-network are upregulated in infants born to
arsenic-exposed mothers (Figure 3A).
The second sub-network integrates biomarker member
DUSP1 with two stress-activated transcription factors;
namely, signal transducer and activator of transcription
(STAT1) and hypoxia inducible factor-1 a (HIF-1a) (Figure
3B). Transcripts for both STAT1 and HIF-1a were upregulated
in infants with arsenic-exposed mothers (Figure 3B). STAT1 is
involved in cytokine signal transduction and is known to be
activated by arsenic [19]. HIF-1a activation and resultant
tumorigenesis has been linked to chronic arsenic exposure
[20].
The third sub-network integrates four of the 11 potential
arsenic biomarkers; namely, EGR-1, OSM, PTGS2, and JUNB
(Figure 3C). These arsenic biomarker gene products are
highly integrated with proteins known to be involved in cell
cycle regulation, including JUN and FOS, as well as stress-
response proteins such as interleukin-8 (IL-8) (Figure 3C). An
overlay of molecular processes represented in this sub-
network highlights the ﬁnding that prenatal arsenic exposure
modulates numerous biological processes including stress
response, signal transduction, cell adhesion, and transcrip-
tion (Figure 3C).
Using network analyses, we also established that there are
known molecular interactions among the 11 potential arsenic
biomarker genes. Eight of the 11 biomarker gene products
(exclusive of SFRS5, MIRN21, and RNF149) are highly
integrated with tumor necrosis factor-a (TNF-a), another
proinﬂammatory cytokine (Figure 3D). TNF-a is involved in
the control of both cell proliferation and apoptosis [21].
Here, we identify TNF-a activation in newborn cord blood
upon exposure to prenatal arsenic.
Evidence for Arsenic-Activated Transcriptional Control of
Prenatal Responses
In an effort to uncover potential regulatory mechanisms
underlying the transcription of the arsenic-modulated gene
sets, we performed transcription factor binding site analysis
within the promoters of the arsenic-modulated genes
(Materials and Methods). Promoter region comparisons for
the arsenic-modulated genes identiﬁed signiﬁcant enrich-
ment (p , 0.05) for two transcription factor binding sites
across all four gene sets. Speciﬁcally, binding sites for NF-jB
and serum response factor (SRF) are enriched in all four
arsenic-modulated gene sets (Table 4). Moreover, metal
Table 2. Gene Ontology Enrichment
Gene Ontology
Category
Gene Ontology
Number
FDR
q-Value
Immune response GO:0006955 p , 0.001
Inflammatory response GO:0006954 p , 0.001
Response to stress GO:0006950 p , 0.001
Response to other organism GO:0051707 p , 0.001
Response to pest, pathogen, or parasite GO:0009613 p , 0.001
Response to wounding GO:0009611 p , 0.001
Response to biotic stimulus GO:0009607 p , 0.001
Response to external stimulus GO:0009605 p , 0.001
Cytokine activity GO:0005125 p , 0.001
Cell death GO:0008219 0.0008
Genes differentially expressed between arsenic unexposed and exposed newborns were
analyzed for significant enrichment of gene ontology categories.
doi:10.1371/journal.pgen.0030207.t002
Figure 2. Prenatal Arsenic Exposure Results in Robust Genome-Wide
Changes
(A) Heat map of the 447 differentially expressed genes identified
between two newborn populations, those born to unexposed or arsenic
exposed mothers. The cut point of exposure is indicated with a red
dotted line. Unlike Figure 1, the differentially expressed transcripts did
not have to display a significant trend with increasing arsenic exposure.
Expression values are mean centered with high relative expression
indicated in red and low relative expression indicated in blue.
(B) The 285 arsenic-modulated gene products existing in the Ingenuity
database were analyzed for significant enrichment of molecular
interactions. A significant (p , 10
 55) interactome containing 105
arsenic-modulated gene products was identified. Proteins in red
represent arsenic-induced transcripts, proteins in green represent
arsenic-repressed transcripts.
doi:10.1371/journal.pgen.0030207.g002
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responsive transcription factor-1 (MTF1) are enriched in
three of the four gene sets (sets 1, 3, and 4) (Table 4). The
MTF1 binding site enrichment was highest for the third gene
set with ﬁve of the 11 genes containing the MRE element
(Figure 3D). Notably, the enrichment for MTF1 in the second
gene set only narrowly misses the enrichment p , 0.05 cutoff,
at p ¼ 0.054 (Table 4). MTF1 was shown to be activated upon
arsenic exposure in animal models [23,24]. It is noteworthy
that gene targets for a known arsenic-inducible transcription
factor are found among the transcripts modulated in the cord
blood of infants born to arsenic exposed mothers.
NF-jB and Inflammation Signaling Identified in Arsenic-
Exposed Newborns from Ron Pibul and Common Arsenic-
Induced Stress Signaling across Species
As the unexposed samples utilized in this study were
obtained from two different locations and could confound
expression testing, we have used an alternative approach to
substantiate the identiﬁed arsenic-induced pathways. Differ-
ential expression testing was performed between the cord
blood of exposed and unexposed newborns from Ron Pibul
(Materials and Methods). These analyses identiﬁed 321 genes
that were differentially expressed between the arsenic-
unexposed and -exposed newborns (Table S5). Notably, a
direct comparison of gene expression changes identiﬁed
considerable overlap between the transcripts differentially
expressed between the newborns from Ron Pibul and
transcripts differentially expressed across the whole popula-
tion (fourth gene set) (Table S5).
To identify the biological pathways modulated by prenatal
arsenic exposure, the proteins encoded by the 321 transcripts
were analyzed for signiﬁcant enrichment of molecular
networks (Materials and Methods). Three highly signiﬁcant
protein sub-networks (p , 10
 30) were identiﬁed (Figure S3).
As with the network ﬁndings from the entire population of
newborns, the networks identiﬁed here integrate proteins
known to be involved in cell cycle regulation including JUN,
as well as stress-response proteins such as interleukin-8 (IL-8),
the pro-inﬂammatory interleukin 1 family member IL1-b, and
hypoxia inducible factor-1 a (HIF-1a) (Figure S3). Further-
more, the NF-jB protein is integrated into the sub-networks
and found to be activated in the cord blood of newborns
exposed to arsenic within the Ron Pibul population (Figure
S3).
Finally, our analyses included comparisons of the gene
expression changes identiﬁed in this study with arsenic-
induced gene expression changes reported in the literature in
mouse models as well as a separate arsenic-exposed human
population. Our results were compared with (i) expression
changes in livers of mice treated with arsenic [24], (ii)
expression changes identiﬁed in arsenic-induced tumors
resulting from in utero exposures to arsenic in mice [6],
and (iii) expression changes in blood from a human
population from Taiwan exposed to arsenic [25]. These
comparisons identify overlap of similarly modulated tran-
scripts in response to arsenic exposure that include: BCL6 (B-
cell CLL/lymphoma 6), CD14 (CD14 antigen), CXCL1 (chemo-
kine ligand 1), EGR1 (early growth response 1), FOS (v-fos FBJ
murine osteosarcoma), FOSB (FBJ murine osteosarcoma viral
oncogene homolog B), GADD45B (growth arrest and DNA
damage inducible beta), IFNGR1 (interferon gamma receptor
1), IL1B (interleukin 1 beta), IL1R1 (interleukin 1 receptor 1),
JUN (v-jun sarcoma virus oncogene), MAPK6 (mitogen-
activated protein kinase 6), MT1X (metallothionein 1X),
RAD23B (RAD23 homolog B), and TOP1 (topoisomerase
DNA 1) (Tables S3 and S5). These results highlight the
modulation of stress related transcripts in both mice (acute
and in utero exposures) and a separate adult human
population in response to arsenic exposure.
Discussion
Globally, millions of people are at risk for the detrimental
effects of chronic arsenic exposure with drinking water levels
far exceeding the WHO guideline [1]. Prenatal arsenic
exposure in human populations has been associated with
pronounced long-term health consequences [4]. Here, we
address the impact of maternal arsenic exposure on fetal
gene expression in a human population. Our goals were 2-
fold: ﬁrst, to establish the extent to which chronic arsenic
exposure in mothers impacts newborn gene expression, and
second, to identify genes that could be used as potential
biomarkers of prenatal arsenic exposure and targets for
remedial therapy.
Differential expression testing of training populations of
Table 3. GSEA
Gene Set Gene Set Name (Molecular Signatures Database) FDR q-value
Hypoxia/stress response signature Hypoxia_Review 4.74E 03
Breast cancer/estrogen signature Breast_Cancer_Estrogen_Signaling 3.00E 03
Transcription factor-induced signature Gery_Cebp_Targets 2.33E 03
Hypoxia/stress response signature Hypoxia_Reg_Up 3.71E 03
UV-induced signature UVB_Nhek1_Up 2.97E 03
Trichostatin-A-induced signature Tsa_Panc50_Up 2.67E 03
Tumor promoter signature Tpa_Sens_Early_Up 2.48E 03
Tumor progression signature Emt_Dn 2.47E 03
Cytokine-induced signature Croonquist_IL6_Stroma_Up 5.10E 03
Butyrate-induced signature Hdaci_Colon_But2hrs_Up 8.88E 03
GSEA was performed; gene sets from the Molecular Signatures Database were identified as significantly enriched.
doi:10.1371/journal.pgen.0030207.t003
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identiﬁed three arsenic-associated gene expression signatures
comprised of 170, 38, and 11 genes. Analysis of the predictive
capacity of each of these gene sets using the Support Vector
Machine two-class prediction algorithm showed that each of
these gene sets is highly predictive of arsenic exposure in a
test population. Notably, even the smallest gene set com-
prised of 11 genes was powerful, with 83% accuracy in
predicting prenatal arsenic exposure in the test population.
The 11 potential biomarkers of prenatal arsenic exposure
include CXL1, DUSP1, EGR-1, IER2, JUNB, MIRN21, OSM,
PTGS2, RNF149, SFRS5, and SOC3. The set of 11 genes show a
striking dose response to prenatal arsenic exposure. Stress
response and cell cycle regulation are associated molecular
functions of the potential biomarker set. Arsenic exposure is
known to activate stress-related transcripts in yeast, animal
models and human subjects [24–26]. Here, we ﬁnd that stress-
response genes are differentially expressed among a pop-
ulation of newborns whose mothers were exposed to varying
levels of arsenic.
To assess the genome-wide impact of prenatal arsenic
exposure on newborn gene expression, we identiﬁed all
transcripts that showed differential expression between two
populations; the 21 newborns whose mothers had been
exposed to arsenic versus the 11 newborns whose mothers
were unexposed. These analyses identiﬁed ;450 genes
differentially expressed between the two populations, of
which 90% had expression levels that were increased (rather
than decreased) by arsenic exposure. Clearly, there is a robust
genome-wide response to prenatal arsenic exposure with
;3% of the expressed genes signiﬁcantly altered in the
newborn. Gene ontology and GSEA highlight the activation
of stress-related transcripts in the cord blood of infants
exposed prenatally to arsenic.
Furthermore, integration of the gene products of the ;450
transcripts with known molecular interactions identiﬁed the
existence of a large arsenic-modulated interacting network of
105 proteins. Embedded within this large interacting network
are three sub-networks that highlight that prenatal arsenic
exposure activates inﬂammation-related molecules. Speciﬁ-
cally, the ﬁrst of the sub-networks centers around NF-jB and
IL1-b. NF-jB regulates a large number of genes critical for
apoptosis, as well as inﬂammation-related molecules such as
cytokines (interleukins). IL1-b belongs to the class of acute
phase proteins known to be increased in response to
inﬂammation. Links between prenatal arsenic exposure and
the activation of a stress response are also evident in the
second and third sub-networks. Prenatal arsenic exposure
resulted in the induction of the stress-related transcription
factors STAT1 and HIF-1a, both of which are known to be
activated by arsenic in model systems [19]. Here, we identify
STAT1 and HIF-1a activation in newborn cord blood upon
prenatal arsenic exposure. The activation of stress-response
proteins such as interleukin-8 (IL-8) in response to prenatal
arsenic exposure is also evident in sub-network three. The
gene expression signatures identiﬁed here as modulated by
prenatal arsenic exposure were compared to arsenic-induced
gene expression changes in the mouse model and also with a
α
Figure 3. Sub-networks of Prenatal Arsenic-Modulated Gene Products
(A) A sub-network that integrates NF-jB and IL1-b with SOC3 and CXCL1
was identified. Note that SOC3 and CXCL1 are among the 11 potential
gene biomarkers for arsenic exposure shown in Table 1.
(B) A sub-network that integrates STAT1 and HIF1-a with DUSP1.
(C) An EGR-1, OSM, JUNB focused sub-network highlights numerous
biological processes modulated in response to arsenic. Proteins encoded
by 11 potential gene biomarkers for arsenic exposure are indicated with
a red asterisk.
(D) TNF-a–associated network composed of eight core members of the
potential gene biomarkers for arsenic exposure. Biomarker genes with
binding sites for MTF transcription factor are indicated. Proteins in red
represent arsenic-induced transcripts, proteins in green represent
arsenic-repressed transcripts.
doi:10.1371/journal.pgen.0030207.g003
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common pattern of activation of stress-related transcripts in
response to arsenic exposure.
Additionally, eight of the 11 biomarker gene products were
found to have signiﬁcant interactions with the proinﬂamma-
tory cytokine TNF-a. Several studies in animal models have
shown that arsenic exposure results in TNF-a stimulation [27–
29]. In this study, TNF-a activation is identiﬁed in newborn
cord blood upon prenatal arsenic exposure. Taken together,
the network ﬁndings underscore that a mother’s arsenic
exposure results in a robust response in the fetus, indicative of
a systemic inﬂammatory response along with the modulation
of numerous other biological processes including apoptosis,
signal transduction, cell adhesion, and transcription.
We further show that the extensive genome-wide newborn
response to prenatal arsenic exposure may be regulated by at
least three transcription factors. Analysis of the promoter
regions of the arsenic-modulated genes showed enrichment
for NF-jB and SRF in all four arsenic-modulated gene sets.
SRF transcriptionally activates the expression of immediate
early response genes, including C-FOS and EGR-1 [30], two
members of the potential arsenic biomarker set. Moreover,
binding sites for the metal-responsive transcription factor-1
(MTF1) are enriched in three of the four gene sets (sets 1, 3,
and 4). MTF1 was shown to be activated upon arsenic
exposure in animal models [23,24]. That gene targets for a
known arsenic-inducible transcription factor are found
among the transcripts modulated in the cord blood of infants
born to arsenic exposed mothers supports our conclusions
that the transcriptional changes reported here are likely due
to prenatal arsenic exposure.
Our ﬁndings clearly demonstrate the robust impact of a
mother’s arsenic consumption on gene expression in utero as
evidenced by transcript levels in the newborn’s cord blood.
More speciﬁcally, our data suggest that prenatal arsenic
exposure acts as an inﬂammatory stimulus that activates the
NF-jB signaling cascade. NF-jB activation plays a critical role
in inﬂammation-driven tumor progression [31], and thus key
players in tumor progression are modulated in the blood of
newborns exposed to arsenic. To determine the extent to
which these exposures and the resultant expression changes
are associated with susceptibility to disease in later life, the
health status of these children is currently being followed.
Conclusions
In summary, class prediction algorithms identiﬁed gene
expression signatures that predict arsenic exposure in a test
population with about 80% accuracy. Notably, by integrating
training populations with varied exposures, a highly pre-
dictive potential biomarker gene set composed of just 11
genes was identiﬁed. These genes are promising as genetic
biomarkers for prenatal arsenic exposure. Currently, we
cannot eliminate the possibility that the gene expression
signatures identiﬁed here are not absolutely speciﬁc for
arsenic; they may also be predictive of other environmental
exposures, e.g., exposure to other heavy metals. Nevertheless,
this study underscores that there is a robust prenatal
response that correlates with arsenic-exposure levels that
could modulate numerous biological pathways including
apoptosis, cell signaling, the inﬂammatory response, and
other stress responses, and ultimately affect health status.
Arsenic contamination of the drinking water in the Ron Pibul
area of Thailand is representative of that seen in many other
areas of South East Asia, most notably Bangladesh [9],
suggesting that prenatal exposures are likely to be endemic
in these areas. Moreover, arsenic contamination of the Ron
Pibul drinking water is roughly the same as that known to be
present in many of the western United States [2,9], suggesting
that prenatal arsenic exposure may also be a problem in the
United States. These data contribute to our understanding of
biological responses upon arsenic exposure, and show that
prenatal exposure in humans results in measurable pheno-
typic responses in the newborn.
Materials and Methods
Study locations and subjects. The study was conducted in Bangkok
and the Ron Pibul District of the Nakhon Sri Thammarat Province
located in the southern peninsula of Thailand (Figure S1). Five
villages in the Ron Pibul district were selected for the study location
as they had been classiﬁed as high level arsenic contaminated areas,
and arsenicosis had been reported there [8]. Arsenicosis has not been
reported in Central Thailand, speciﬁcally Bangkok, where arsenic
concentrations in water and soil have been determined to be very low
[8]. The study subjects consisted of 32 pregnant women (20–40 y old).
All subjects were healthy, pregnant volunteers undergoing vaginal
childbirth without birth stimulation or anesthesia. Twenty-three
pregnant women living in the Ron Pibul District and nine women
living in Bangkok for at least 1 y were recruited for the study. Women
from both sites were age, educational level, and socioeconomically
matched. Questionnaires were administered to all participants to
obtain personal information regarding residential history, health
history and potential confounding factors, birth and pregnancy
information (number of births, abortions or complications), use of
community drinking water and well water, plus water and food
consumption habits. Cord blood samples were collected from January
2004 to December 2005 in the Ron Pibul Hospital (Ron Pibul District)
and the Rajvithi Hospital (Bangkok). This study was conducted
according to the recommendations of the Declaration of Helsinki
(World Medical Association 1989) for international health research.
All subjects gave written informed consent to participate in this
study.
Table 4. Transcription Factor Binding Site Enrichment
Transcription
Factor
Description Gene Set p-Values
First (170 Genes) Second (38 Genes) Third (11 Genes) Fourth (447 Genes)
SRF Serum response factor 8.46 3 10
 4 0.011 0.008 1.7 3 10
 5
NF-kB Nuclear factor-jB 1.39 3 10
 4 0.011 0.011 8.52 3 10
 6
MTF-1 Metal transcription factor 0.0173 0.054 0.007 0.021
Four arsenic-associated gene sets were analyzed for significant enrichment of transcription factor binding sites. Binding sites for three transcription factors were identified as enriched (p-
values for significance are shown).
doi:10.1371/journal.pgen.0030207.t004
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were asked to provide toenail samples during pregnancy for analysis
of total arsenic concentration, which was determined by Inductively
Coupled Plasma-Mass Spectrometry (ICP-MS) (Agilent 7500c). After
delivery, 2.5 ml of newborn cord blood was collected into a PAXgene
Blood RNA (Qiagen) tube for study of gene expression. All cord blood
samples were kept at  70 8C until analysis.
Microarray analysis. Total RNA was isolated from 32 cord blood
samples according to the PAX gene protocol and Qiagen RNA
extraction kit. RNA was labeled using a globin reduction protocol
(Affymetrix) and hybridized to HGU133 Plus 2.0 full genome human
arrays in technical duplicate for a total of 64 arrays. Data were ﬁrst
normalized using Robust Multi-Chip Average (RMA) [32] and ﬁltered
for expressed transcripts across all arrays (þ2 standard deviations
above mean background) resulting in reduction of the probesets from
the original 54,675 to 15,265. A mean absolute expression value was
calculated from technical duplicates of the arrays for all expressed
transcripts. Differential gene expression and association with
increasing arsenic concentration was calculated as follows. The
samples comprising the training sets were separated into two groups
based on arsenic exposure level. The two groups were unexposed
(maternal toenail ,0.5 lg/g) or exposed (maternal toenail  0.5 lg/g).
The two-class exposure designation is based on the WHO standards
for exposure to arsenic of 10 lg/l arsenic. A mean toenail arsenic
concentration of 0.5 lg/g corresponding to chronic consumption of
drinking water at 10 lg/l arsenic was derived from two studies
associating arsenic toenail concentration and drinking water in a
population from Bangladesh [12] and the United States [11]. Differ-
ential expression was determined as a signiﬁcant difference in the
expression of a gene (exposed versus unexposed) where the average
fold change was greater thanþ/ 1.5 and p , 0.05 (t-test). Additionally,
signiﬁcant association of gene expression and increasing arsenic level
was determined by correlation measurements (r
2  þ 0.6, r
2    0.6; p ,
0.01) calculated using the linear regression model in S-PLUS 7.0
(http://www.insightful.com). The two-class prediction model used for
assessing arsenic exposure in test populations was Support Vector
Machine, carried out in Gene Pattern Software (version 2.0.1) (http://
www.broad.mit.edu). Multivariate analysis was performed as follows:
the expression values (Y) for each gene were modeled using Y¼b1þb2
ars (arsenic) þ b3 loc (geographic location), where toenail arsenic
concentration is a continuous variable and location is binary.
Statistical signiﬁcance was determined by subjecting b2 and b3 to t-
statistics. A v
2 test for dependence (association) of the two factors
(e.g., arsenic and geographic location) was performed for the set of
arsenic biomarkers. A Fisher’s exact test was employed to determine
overrepresentation of the biomarkers within the genes signiﬁcantly
associated with either geographic source or arsenic exposure (p ,
0.01). Network analyses were performed using the Ingenuity software
(http://www.ingenuity.com). Gene ontology enrichment analysis was
performed using GO Miner [33]. GSEA [34] was performed using the
GSEA desktop software [35], with a false discovery rate correction
(Benjamini-Hochberg) employed. Microarray data have been depos-
ited to the Gene Expression Omnibus repository.
Transcription factor binding site analysis. Transcription factor
binding site analysis was performed using Expander software [36] and
Genomatix software (http://www.genomatix.de). For both analyses,
Affymetrix probesets were linked to sequence data for regions 1,000
base pairs upstream and 200 base pairs downstream of the tran-
scription start sites, and these were analyzed for signiﬁcant enrich-
ment of transcription factor binding sites. Signiﬁcance (p   0.05) was
calculated where signiﬁcance is the probability of obtaining an equal
or greater number of sequences with a model match in a randomly
drawn sample of the same size as the input sequence set.
Supporting Information
Figure S1. Map of Study Location
The study was conducted in Bangkok and the Ron Pibul District of
the Nakhon Sri Thammarat Province located in the southern
peninsula of Thailand. Study locations are indicated with red circles.
Found at doi:10.1371/journal.pgen.0030207.sg001 (6.3 MB AI).
Figure S2. Expression Patterns of 11 Biomarkers of Prenatal Arsenic
Exposure
Transcripts that are predictive of prenatal arsenic exposure are
plotted with expression intensity versus arsenic exposure.
Found at doi:10.1371/journal.pgen.0030207.sg002 (615 KB AI).
Figure S3. Arsenic-Modulated Sub-networks Identiﬁed from Differ-
entially Expressed Genes from the Ron Pibul Population
Signiﬁcant sub-networks of arsenic-modulated gene products were
identiﬁed between the unexposed and exposed newborn populations
of Ron Pibul.
Found at doi:10.1371/journal.pgen.0030207.sg003 (10.9 MB AI).
Table S1. Genes Differentially Expressed between Newborns That
Composed the First Training Population
A total of 170 genes were differentially expressed between newborns
born to mothers unexposed to arsenic and newborns born to mothers
exposed to arsenic that composed the ﬁrst training population.
Found at doi:10.1371/journal.pgen.0030207.st001 (54 KB DOC).
Table S2. Genes Differentially Expressed between Newborns That
Composed the Second Training Population
A total of 38 genes were identiﬁed as differentially expressed between
newborns born to mothers unexposed to arsenic and newborns born
to mothers exposed to arsenic that composed the second training
population.
Found at doi:10.1371/journal.pgen.0030207.st002 (29 KB DOC).
Table S3. Genes Differentially Expressed between Two Newborn
Populations; Those Born to Mothers Unexposed to Arsenic and
Those Born to Mothers Exposed to Arsenic
A total of 447 genes were identiﬁed as differentially expressed
between the two newborn populations; those newborns born to
mothers unexposed to arsenic or to mothers exposed to arsenic.
Found at doi:10.1371/journal.pgen.0030207.st003 (122 KB DOC).
Table S4. Arsenic-Modulated Gene Products
A total of 105 arsenic modulated gene products are contained in a
signiﬁcant large interactome (p , 10
 55).
Found at doi:10.1371/journal.pgen.0030207.st004 (38 KB DOC).
Table S5. Genes Differentially Expressed between Arsenic-Unexposed
and -Exposed Newborns in Ron Pibul
A list of the 321 genes differentially expressed between the two
newborn populations from the Ron Pibul Province; those born to
mothers unexposed to arsenic, and those born to mothers exposed to
arsenic.
Found at doi:10.1371/journal.pgen.0030207.st005 (85 KB DOC).
Accession Numbers
Microarray data have been deposited to the National Center for
Biotechnology Information (NCBI) Gene Expression Omnibus repo-
sitory under Series Record GSE7967 (www.ncbi.nlm.nih.gov/geo/).
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